|
|
Article: Study shows Genentech's cancer fighter Avastin helps sickest patients.
- Article from:
- Cancer Weekly
- Article date:
- December 21, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 DEC 21 - (NewsRx.com & NewsRx.net) -- Genentech Inc. said November 29, 2004, its novel colon cancer-fighting drug Avastin helped some of the sickest patients stay alive 2 months longer than expected, giving the drug an additional boost on its way to blockbuster status.
The South San Francisco-based biotechnology titan made the announcement ahead of a major conference for cancer researchers and doctors scheduled for January, when the company said it would release more detailed results from a large-scale human experiment using Avastin in combination with a chemotherapy treatment.
"This study provides additional evidence that adding Avastin to ...